These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

49 related items for PubMed ID: 15321035

  • 1. Treatment response in HCV related chronic hepatitis.
    Hussain AB, Hussain T, Anwar M, Hussain S, Kazmi Y, Tariq WU, Karamat KA.
    J Coll Physicians Surg Pak; 2004 Aug; 14(8):466-9. PubMed ID: 15321035
    [Abstract] [Full Text] [Related]

  • 2. Outcome of combined interferon-ribavirin in the treatment of chronic hepatitis C.
    Muhammad N, Jan MA, Rahman N.
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):651-3. PubMed ID: 15530272
    [Abstract] [Full Text] [Related]

  • 3. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Nov; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 4. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
    Cornberg M, Hadem J, Herrmann E, Schuppert F, Schmidt HH, Reiser M, Marschal O, Steffen M, Manns MP, Wedemeyer H.
    J Hepatol; 2006 Feb; 44(2):291-301. PubMed ID: 16360972
    [Abstract] [Full Text] [Related]

  • 5. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Kobayashi M, Arase Y, Ikeda K, Kumada H.
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J.
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [Abstract] [Full Text] [Related]

  • 7. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis.
    Watkins-Riedel T, Ferenci P, Steindl-Munda P, Gschwantler M, Mueller C, Woegerbauer M.
    Clin Infect Dis; 2004 Dec 15; 39(12):1754-60. PubMed ID: 15578395
    [Abstract] [Full Text] [Related]

  • 8. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T.
    Hepatology; 2005 Jan 15; 41(1):106-14. PubMed ID: 15619235
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
    Kawai S, Yokosuka O, Imazeki F, Saisho H, Mizuno C.
    J Med Virol; 2002 Nov 15; 68(3):343-51. PubMed ID: 12226820
    [Abstract] [Full Text] [Related]

  • 10. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
    Januszkiewicz-Lewandowska D, Wysocki J, Pernak M, Nowicka K, Zawada M, Rembowska J, Lewandowski K, Mańkowski P, Nowak J.
    Jpn J Infect Dis; 2007 Feb 15; 60(1):29-32. PubMed ID: 17314422
    [Abstract] [Full Text] [Related]

  • 11. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML.
    Antivir Ther; 2005 Feb 15; 10(1):125-33. PubMed ID: 15751770
    [Abstract] [Full Text] [Related]

  • 12. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML, Chuang WL, Dai CY, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Tsai SL, Kuo HT.
    Transl Res; 2006 Sep 15; 148(3):120-7. PubMed ID: 16938649
    [Abstract] [Full Text] [Related]

  • 13. Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection.
    Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreño V.
    Aliment Pharmacol Ther; 2009 Sep 01; 30(5):477-86. PubMed ID: 19523175
    [Abstract] [Full Text] [Related]

  • 14. [Clinical benefit of HCV core antigen assay in patients receiving interferon and ribavirin combination therapy].
    Higashimoto M, Takahashi M, Jokyu R, Saito H.
    Rinsho Byori; 2006 Feb 01; 54(2):111-5. PubMed ID: 16548229
    [Abstract] [Full Text] [Related]

  • 15. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA.
    Transplant Proc; 2004 Feb 01; 36(6):1831-4. PubMed ID: 15350490
    [Abstract] [Full Text] [Related]

  • 16. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO, Schuchmann M, Link R, Hillenbrand H, Rahman F, Sprinzl M, Mudter J, Löhr HF, Galle PR.
    Liver Int; 2006 Apr 01; 26(3):319-25. PubMed ID: 16584394
    [Abstract] [Full Text] [Related]

  • 17. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
    Fujita N, Kaito M, Kai M, Sugimoto R, Tanaka H, Horiike S, Konishi M, Iwasa M, Watanabe S, Adachi Y.
    J Viral Hepat; 2006 Jul 01; 13(7):441-8. PubMed ID: 16792537
    [Abstract] [Full Text] [Related]

  • 18. Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays.
    Sarrazin C, Teuber G, Kokka R, Rabenau H, Zeuzem S.
    Hepatology; 2000 Oct 01; 32(4 Pt 1):818-23. PubMed ID: 11003628
    [Abstract] [Full Text] [Related]

  • 19. Significance of occult HBV infection in patients with chronic hepatitis C.
    Anwar W, Sarwar M, Hussain AB, Tariq WU, Saif M.
    J Coll Physicians Surg Pak; 2006 Mar 01; 16(3):192-5. PubMed ID: 16542598
    [Abstract] [Full Text] [Related]

  • 20. Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection.
    McHutchison JG, Blatt LM, Ponnudurai R, Goodarzi K, Russell J, Conrad A.
    J Med Virol; 1999 Apr 01; 57(4):351-5. PubMed ID: 10089045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.